Literature DB >> 33499867

Building a precision oncology workforce by multidisciplinary and case-based learning.

Srikar Chamala1, Heather T D Maness2, Lisa Brown3, C Brooke Adams4, Jatinder K Lamba5, Christopher R Cogle6.   

Abstract

BACKGROUND: Participants in two recent National Academy of Medicine workshops identified a need for more multi-disciplinary professionals on teams to assist oncology clinicians in precision oncology.
METHODS: We developed a graduate school course to prepare biomedical students and pharmacy students to work within a multidisciplinary team of oncology clinicians, pathologists, radiologists, clinical pharmacists, and genetic counselors. Students learned precision oncology skills via case-based learning, hands-on data analyses, and presentations to peers. After the course, a focus group session was conducted to gain an in-depth student perspective on their interprofessional training experience, achievement of the course learning outcomes, ways to improve the course design in future offerings, and how the course could improve future career outcomes. A convenience sampling strategy was used for recruitment into the focus group session. A thematic content analysis was then conducted using the constant comparative method.
RESULTS: Major themes arising from student feedback were (1) appreciation of a customized patient case-based teaching approach, (2) more emphasis on using data analysis tools, (3) valuing interdisciplinary inclusion, and (4) request for more student discussion with advanced preparation materials.
CONCLUSIONS: Feedback was generally positive and supports the continuation and expansion of the precision oncology course to include more hands-on instruction on the use of clinical bioinformatic tools.

Entities:  

Keywords:  Case-based learning; Graduate medical education; Precision oncology

Mesh:

Year:  2021        PMID: 33499867      PMCID: PMC7836489          DOI: 10.1186/s12909-021-02500-6

Source DB:  PubMed          Journal:  BMC Med Educ        ISSN: 1472-6920            Impact factor:   2.463


  10 in total

1.  Implementing Precision Medicine in Community-Based Oncology Programs: Three Models.

Authors:  Laura A Levit; Edward S Kim; Barbara L McAneny; Lincoln D Nadauld; Kathryn Levit; Caroline Schenkel; Richard L Schilsky
Journal:  J Oncol Pract       Date:  2019-02-25       Impact factor: 3.840

2.  Improving Cancer Diagnosis and Care: Patient Access to Oncologic Imaging Expertise.

Authors:  Sharyl J Nass; Christopher R Cogle; James A Brink; Curtis P Langlotz; Erin P Balogh; Ada Muellner; Dana Siegal; Richard L Schilsky; Hedvig Hricak
Journal:  J Clin Oncol       Date:  2019-05-03       Impact factor: 44.544

3.  Support systems to guide clinical decision-making in precision oncology: The Cancer Core Europe Molecular Tumor Board Portal.

Authors:  David Tamborero; Rodrigo Dienstmann; Maan Haj Rachid; Jorrit Boekel; Richard Baird; Irene Braña; Luigi De Petris; Jeffrey Yachnin; Christophe Massard; Frans L Opdam; Richard Schlenk; Claudio Vernieri; Elena Garralda; Michele Masucci; Xenia Villalobos; Elena Chavarria; Fabien Calvo; Stefan Fröhling; Alexander Eggermont; Giovanni Apolone; Emile E Voest; Carlos Caldas; Josep Tabernero; Ingemar Ernberg; Jordi Rodon; Janne Lehtiö
Journal:  Nat Med       Date:  2020-07-06       Impact factor: 53.440

Review 4.  Clinical Application of Computational Methods in Precision Oncology: A Review.

Authors:  Orestis A Panagiotou; Lori Hoffman Högg; Hedvig Hricak; Samir N Khleif; Mia A Levy; David Magnus; Martin J Murphy; Bakul Patel; Robert A Winn; Sharyl J Nass; Constantine Gatsonis; Christopher R Cogle
Journal:  JAMA Oncol       Date:  2020-08-01       Impact factor: 31.777

Review 5.  Clonal evolution in cancer.

Authors:  Mel Greaves; Carlo C Maley
Journal:  Nature       Date:  2012-01-18       Impact factor: 49.962

6.  Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.

Authors:  Christophe Le Tourneau; Jean-Pierre Delord; Anthony Gonçalves; Céline Gavoille; Coraline Dubot; Nicolas Isambert; Mario Campone; Olivier Trédan; Marie-Ange Massiani; Cécile Mauborgne; Sebastien Armanet; Nicolas Servant; Ivan Bièche; Virginie Bernard; David Gentien; Pascal Jezequel; Valéry Attignon; Sandrine Boyault; Anne Vincent-Salomon; Vincent Servois; Marie-Paule Sablin; Maud Kamal; Xavier Paoletti
Journal:  Lancet Oncol       Date:  2015-09-03       Impact factor: 41.316

7.  Mutational landscape and significance across 12 major cancer types.

Authors:  Cyriac Kandoth; Michael D McLellan; Fabio Vandin; Kai Ye; Beifang Niu; Charles Lu; Mingchao Xie; Qunyuan Zhang; Joshua F McMichael; Matthew A Wyczalkowski; Mark D M Leiserson; Christopher A Miller; John S Welch; Matthew J Walter; Michael C Wendl; Timothy J Ley; Richard K Wilson; Benjamin J Raphael; Li Ding
Journal:  Nature       Date:  2013-10-17       Impact factor: 49.962

8.  Informatics Training for Pathology Practice and Research in the Digital Era.

Authors:  Heather T D Maness; Linda S Behar-Horenstein; Michael Clare-Salzler; Srikar Chamala
Journal:  Acad Pathol       Date:  2020-03-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.